FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
+5.06%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$239M
AUM Growth
–
Cap. Flow
+$239M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Glaukos
GKOS
|
$64.3M |
| 2 |
Collegium Pharmaceutical
COLL
|
$51.6M |
| 3 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$32.9M |
| 4 |
Amicus Therapeutics
FOLD
|
$28.3M |
| 5 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$26.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Glaukos
GKOS
$5.5B
| $64.3M | 26.88% | +2,603,362 | New | +$64.3M |
|
|
2
Collegium Pharmaceutical
COLL
$1.22B
| $51.6M | 21.59% | +1,877,332 | New | +$51.6M |
|
|
SRRA
3
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $32.9M | 13.75% | +2,186,195 | New | +$32.9M |
|
|
4
Amicus Therapeutics
FOLD
$2.34B
| $28.3M | 11.84% | +2,918,291 | New | +$28.3M |
|
|
TBRA
5
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $26.8M | 11.21% | +2,668,570 | New | +$26.8M |
|
6
Cidara Therapeutics
CDTX
$1.66B
| $22.5M | 9.42% | +1,312,258 | New | +$22.5M |
|
|
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
| $12.7M | 5.32% | +950,366 | New | +$12.7M |
|